Japanese Government Procurement

National University Corporation - Notice of Procurement (Goods & Services)A Nusinersen Sodium (12mg5mL/1vial) 5 vials,Ｂ　Infliximab (GeneticalRecombination) (100mg／1vial) 360 vials,Ｃ　Pembrolizumab (Genetical Recombination) (100mg4mL／1vial) 70 vials

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Jan 16, 2020
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National University Corporation - Yamaguchi
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Masaaki Oka, President Yamaguchi University
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
A Nusinersen Sodium (12mg5mL/1vial) 5 vials
B Infliximab (GeneticalRecombination) (100mg/1vial) 360 vials
C Pembrolizumab (Genetical Recombination) (100mg4mL/1vial) 70 vials
⑷ Delivery period : From 1 April, 2020 through 31 March, 2021
⑸ Delivery place : The places specified by the Obligating Officer
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 5 and 6 of the Regulation concerning the Contract for Yamaguchi University Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,
B have the Grade A, Grade B or Grade C qualification during fiscal 2020 in the Chugoku area in sales of product for participating in tenders by Single qualification for every ministry and agency,
C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,
D meet the qualification requirements which President Yamaguchi University may specify in accordance with Article 7 of the Regulation,
E not be currently under a suspension of business order as instructed by President Yamaguchi University.
⑺ Time limit of tender : 17 : 00 10 March, 2020
⑻ Contact point for the notice : Yasushi Akita, Medicine and Medical Instruments, Accounting Division, School of Medicine, Yamaguchi University, 1-1-1 Minami- kogushi Ube-shi 755-8505 Japan, TEL 0836-22-2035
⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.